In this unique experimental approach, we first found in silico that in human cohorts included in TCGA, Id1 expression inversely correlates with the mRNA expression levels of several markers related to immune response and that the suppression of Id1 promotes PD-L1 expression on the tumor cell surface irrespective of KRAS status. The gene discussed is KRAS; the disease is neoplasm.